Morgan Stanley predicts Eli Lilly shares to rally on Novo's obesity drug data

United States News News

Morgan Stanley predicts Eli Lilly shares to rally on Novo's obesity drug data
United States Latest News,United States Headlines
  • 📰 CNBC
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 72%

Morgan Stanley sees Eli Lilly shares rallying on data showing heart benefit of Novo's obesity drug

Danish drugmaker Novo Nordisk 's promising data on its obesity drug Wegovy should benefit Eli Lilly 's pipeline and its stock, according to Morgan Stanley. Shares of Novo Nordisk soared 15% in early trading Tuesday after late-stage trial data showed that Wegovy reduced the risk of major cardiovascular events, such as heart attacks or strokes, by 20%, compared with a placebo. "This is above our expectations and our prior analysis," Morgan Stanley analyst Terence Flynn said.

The analyst said Eli Lilly's stock could rally at least 5% on this news as the positive data could pave the way for more insurance coverage of obesity treatments already in the Indianapolis drugmaker's pipeline. "We expect LLY shares to trade up > 5%, given this data should continue to build the case for broader insurance coverage of obesity drugs, such as LLY's Mounjaro, where a separate Ph3 outcomes trial is ongoing," Flynn said.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CNBC /  🏆 12. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Morgan Stanley still likes these Chinese stocks despite a country downgradeMorgan Stanley still likes these Chinese stocks despite a country downgradeUncertainty is rising for the giant emerging market class of Chinese stocks.
Read more »

Morgan Stanley names 3 high-conviction global stock ideas, says one could soar 40%Morgan Stanley names 3 high-conviction global stock ideas, says one could soar 40%The Wall Street bank's 'actionable ideas' include one of the world's largest semiconductor chip companies.
Read more »

'Barbenheimer' can boost Cinemark shares more than 35% from here, Morgan Stanley says'Barbenheimer' can boost Cinemark shares more than 35% from here, Morgan Stanley saysDespite the overhang of the Hollywood labor strikes, 'a significant bull case remains' for Cinemark, according to Morgan Stanley.
Read more »

Morgan Stanley warns of hit to equity valuation if US fiscal spending is cutMorgan Stanley warns of hit to equity valuation if US fiscal spending is cutMorgan Stanley cautions that the high valuation of US equities may be affected if aggressive fiscal spending is reduced, following the downgrade of sovereign debt by Fitch. The brokerage highlights the significant fiscal stimulus implemented in response to the COVID-19 pandemic, which has allowed the US economy to outperform expectations. Despite the Federal Reserve's rapid interest rate hikes, some Wall Street strategists anticipate a continued rally for certain US stocks.
Read more »

Morgan Stanley believes this aviation-rooted stock is a great buyMorgan Stanley believes this aviation-rooted stock is a great buyAccording to analysts at Morgan Stanley, a defense contractor with a history tracing back to aviation pioneers Glenn Curtiss and the Wright Brothers is considered a valuable asset and presents a great investment opportunity.
Read more »

Eli McCann: Welcome to a Big Fat Mormon Wedding — where cousins arrive by the dozensEli McCann: Welcome to a Big Fat Mormon Wedding — where cousins arrive by the dozensSalt Lake Tribune guest columnist Eli McCann talks about large Latter-day Saint families and their big, yet not-so-big, weddings.
Read more »



Render Time: 2025-02-24 01:26:54